Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEngage Xr Regulatory News (EXR)

Share Price Information for Engage Xr (EXR)

Share Price is delayed by 15 minutes
Get Live Data
0.25    0.00 (0.00%)
Bid:
0.20
Ask:
0.30
Spread: 0.10 (50.00%)
Market Cap: £1.31m
EXR Live PriceLast checked at - London Stock Exchange

Intraday Engage Xr Share Chart

EPT Disclosure

22 Apr 2008 11:37

UBS AG (EPT)22 April 2008 FORM 38.5(b) DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RI STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(b) of the Takeover Code) 1. KEY INFORMATION Name of exempt principal trader UBS AG London BranchCompany dealt in Expro International Group PlcClass of relevant security to which the 10p Ordinarydealings being disclosed relate (Note 1)Date of dealing 21 APRIL 2008 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2) Long Short Number (%) Number (%)(1) Relevant securities 552,504 0.50% 0 0.00%(2) Derivatives (other thanoptions)(3) Options and agreements topurchase/sellTotal 552,504 0.50% 0 0.00% (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2) Class of relevant security: Long Short Number (%) Number (%)(1) Relevant securities(2) Derivatives (other thanoptions)(3) Options and agreements topurchase/sellTotal (c) Rights to subscribe (Note 2)Class of relevant security: Details 3. DEALINGS (Note 3) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 4) PURCHASE 300 1487 pence PURCHASE 300 1487 PURCHASE 300 1487 PURCHASE 3000 1490 SALE 600 1492 PURCHASE 374 1492 PURCHASE 300 1494 SALE 3 1495 PURCHASE 1050 1495 SALE 2100 1496 PURCHASE 125 1496 SALE 17 1496.5 SALE 904 1497 SALE 758 1497 SALE 523 1497 SALE 500 1497 SALE 362 1497 SALE 300 1497 SALE 200 1497 SALE 134 1497 SALE 20 1497 SALE 17 1497 SALE 17 1497 PURCHASE 17 1497 PURCHASE 71 1497 PURCHASE 75 1497 PURCHASE 132 1497 PURCHASE 271 1497 PURCHASE 316 1497 PURCHASE 350 1497 PURCHASE 362 1497 PURCHASE 367 1497 PURCHASE 398 1497 PURCHASE 162 1498 PURCHASE 232 1498 PURCHASE 341 1498 PURCHASE 371 1498 PURCHASE 395 1498 PURCHASE 458 1498 PURCHASE 536 1498 PURCHASE 782 1498 PURCHASE 800 1498 PURCHASE 925 1498 PURCHASE 1419 1498 SALE 965 1499 SALE 755 1499 SALE 700 1499 SALE 400 1499 SALE 356 1499 PURCHASE 357 1499 SALE 17 1499.5 PURCHASE 17 1499.5 PURCHASE 186 1500 PURCHASE 365 1500 PURCHASE 1000 1500 PURCHASE 1000 1500 PURCHASE 1250 1500 SALE 400 1501 SALE 239 1501 SALE 200 1501 SALE 170 1501 SALE 170 1501 SALE 100 1501 PURCHASE 351 1501 SALE 500 1502 SALE 322 1502 SALE 200 1502 SALE 200 1502 SALE 158 1502 SALE 157 1502 SALE 154 1502 SALE 100 1502 SALE 100 1502 SALE 7 1502 PURCHASE 271 1502 SALE 150 1503 SALE 137 1503 SALE 100 1503 SALE 100 1503 SALE 93 1503 PURCHASE 1300 1503 SALE 864 1507 SALE 300 1509 SALE 28 1509 PURCHASE 28 1509 TOTAL PURCHASES 20,654 TOTAL SALES 14,597 (b) Derivatives transactions (other than options)Product name, e.g Long/short (Note 5) Number of securities Price per unitCFD (Note 6) (Note 4) (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, e.g. Expiry Optionname,e.g. selling, securities price American, date money paid/call purchasing, to which the European received peroption varying etc option etc. unit (Note relates 4) (Note 6) (ii) Exercising Product name, e.g. call Number of securities Exercise price per unitoption (Note 4) (d) Other dealings (including new securities) (Note 3) Nature of transaction Details Price per unit (if applicable)(Note 7) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. .............................................................................. .............................................................................. Is a Supplemental Form 38.5(b) attached? (Note 8) NO Date of disclosure 22 APRIL 2008Contact name LOUISE ROBINSONTelephone number 020 7567 8762Name of offeree/offeror with which connected Halliburton CompanyNature of connection (Note 9) CONNECTED ADVISER Notes The Notes on Form 38.5(b) can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
31st Aug 20071:43 pmRNSTotal Voting Rights
29th Aug 20072:00 pmRNSNotice of Trading Update
14th Aug 20079:31 amRNSHolding(s) in Company
13th Aug 200711:59 amRNSHolding(s) in Company
1st Aug 20079:44 amRNSBlocklisting Interim Review
31st Jul 20074:21 pmRNSTotal Voting Rights
27th Jul 20072:57 pmRNSDirector/PDMR Shareholding
26th Jul 20077:01 amRNSInterim Management Statement
25th Jul 20078:50 amRNSAdditional Listing
18th Jul 20079:37 amRNSDirector/PDMR Shareholding
18th Jul 20079:36 amRNSDirector/PDMR Shareholding
6th Jul 200712:33 pmRNSDirector/PDMR Shareholding
6th Jul 200712:33 pmRNSDirector/PDMR Shareholding
5th Jul 200712:30 pmRNSCommittee Appointment
5th Jul 200712:30 pmRNSResult of AGM
29th Jun 20074:18 pmRNSTotal Voting Rights
29th Jun 20073:25 pmRNSDirector/PDMR Shareholding
29th Jun 200712:17 pmRNSDirector/PDMR Shareholding
29th Jun 200712:16 pmRNSDirector/PDMR Shareholding
29th Jun 200712:15 pmRNSDirector/PDMR Shareholding
29th Jun 200712:10 pmRNSDirector/PDMR Shareholding
28th Jun 20077:02 amRNSTechnology Conference
27th Jun 20072:35 pmRNSExpro signs LOI for AX-S(TM)
26th Jun 200712:34 pmRNSAnnual Information Update
11th Jun 20073:08 pmRNSHolding(s) in Company
8th Jun 20077:00 amRNSUS Investor Presentation
7th Jun 20076:15 pmRNSAnnual Report and Accounts
1st Jun 200710:54 amRNSBlocklisting Interim Review
31st May 20075:11 pmRNSTotal Voting Rights
31st May 20077:03 amRNSDirectorate Change
31st May 20077:03 amRNSRe Contract
31st May 20077:03 amRNSFinal Results
23rd May 20078:32 amRNSHolding(s) in Company
16th May 200712:19 pmRNSHolding(s) in Company
30th Apr 20074:43 pmRNSTotal Voting Rights
25th Apr 20079:42 amRNSHolding(s) in Company
12th Apr 20077:00 amRNSNotice of Results
10th Apr 20079:20 amRNSHolding(s) in Company
4th Apr 20078:51 amRNSHolding(s) in Company
3rd Apr 20078:58 amRNSHolding(s) in Company
30th Mar 20073:42 pmRNSTotal Voting Rights
27th Mar 20074:08 pmRNSHolding(s) in Company
26th Mar 20077:01 amRNSTrading Statement
19th Mar 20073:05 pmRNSHolding(s) in Company
19th Mar 200712:43 pmRNSHolding(s) in Company
19th Mar 200712:03 pmRNSHolding(s) in Company
12th Mar 20072:38 pmRNSHolding(s) in Company
9th Mar 20073:15 pmRNSHolding(s) in Company
6th Mar 20077:02 amRNSNotice of Trading Update
2nd Mar 20077:30 amRNSDisposal

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.